Paraplegia News and Research

RSS
Paraplegia is an impairment in motor or sensory function of the lower extremities. It is usually the result of spinal cord injury or a congenital condition such as spina bifida which affects the neural elements of the spinal canal.
Neuralstem prices registered direct offering of 7,000,000 shares of common stock

Neuralstem prices registered direct offering of 7,000,000 shares of common stock

Q Therapeutics licenses Neuralstem's Spinal Cord Delivery Platform and Floating Cannula

Q Therapeutics licenses Neuralstem's Spinal Cord Delivery Platform and Floating Cannula

Preliminary research findings from Kessler Foundation’s Ekso device study on SCI

Preliminary research findings from Kessler Foundation’s Ekso device study on SCI

ARGO Medical, Cyclone Technologies announce availability of ReWalk exoskeleton system

ARGO Medical, Cyclone Technologies announce availability of ReWalk exoskeleton system

Exoskeleton technology now available to take home

Exoskeleton technology now available to take home

Neuralstem completes NSI-566 Phase I trial on amyotrophic lateral sclerosis

Neuralstem completes NSI-566 Phase I trial on amyotrophic lateral sclerosis

Advanced understanding of neurodegenerative diseases achieved by Trophos

Advanced understanding of neurodegenerative diseases achieved by Trophos

Neuralstem commences dosing in NSI-189 Phase Ib trial for major depressive disorder

Neuralstem commences dosing in NSI-189 Phase Ib trial for major depressive disorder

Stem Cells reports results of Neuralstem ALS Phase I trial

Stem Cells reports results of Neuralstem ALS Phase I trial

Ekso Bionics, Kessler Foundation partner to test commercial robotic exoskeleton

Ekso Bionics, Kessler Foundation partner to test commercial robotic exoskeleton

Intraoperative monitoring of spinal cord may help prevent paralysis

Intraoperative monitoring of spinal cord may help prevent paralysis

Neuralstem announces registered direct placement of 5,200,000 shares of common stock

Neuralstem announces registered direct placement of 5,200,000 shares of common stock

Kessler scientists monitor Ekso device in six patients with traumatic SCI

Kessler scientists monitor Ekso device in six patients with traumatic SCI

Neuralstem initiates spinal cord neural stem cell trial in ALS

Neuralstem initiates spinal cord neural stem cell trial in ALS

FDA approves intraspinal injections in spinal cord stem cell ALS trial

FDA approves intraspinal injections in spinal cord stem cell ALS trial

Researchers identify unusual genomic architecture linked with very severe forms of disease

Researchers identify unusual genomic architecture linked with very severe forms of disease

DryDiapersPlus joins Unique Wellness and BIOTX to provide incontinence products

DryDiapersPlus joins Unique Wellness and BIOTX to provide incontinence products

Simvastatin may reduce spinal cord damage from ischemia/reperfusion injury

Simvastatin may reduce spinal cord damage from ischemia/reperfusion injury

Neuralstem receives U.S. patent allowance for three new neurogenic compounds

Neuralstem receives U.S. patent allowance for three new neurogenic compounds

Scientists probe 'atlastin,' a protein linked to hereditary spastic paraplegia

Scientists probe 'atlastin,' a protein linked to hereditary spastic paraplegia